Analysts: Micron Technology Has a Material Advantage and 4 New Opinions Investors Must Read

Micron Technology Inc. (NASDAQ:MU): Sterne Agee thinks that the company is the only supplier with DRAM available in any material quantities, and the firm believes that overall DRAM contract trends will continue to be positive into the June quarter. Sterne Agee keeps its Buy rating and $12 price target on the stock.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MU

Newcastle Investment Corp. (NYSE:NCT): UBS has stated that Newcastle Investment weakness is a result of concerns about higher prepayments and the impact on the MSR portfolio and the newly spun New Residential. The analyst views Newcastle’s MSR portfolio as being in the position for potential prepayments, and it believes that shares can outperform. The firm gives the shares a Buy rating and a $14 price target.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

NCT

The Children’s Place Retail Stores, Inc. (NASDAQ:PLCE): According to Citigroup, Children’s Place’s 2013 guidance appears to be conservative, and shares are attractively valued at current levels. The firm has decided to keep its Buy rating and $58 price target on the stock after the company’s Q4 results.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

PLCE

Pioneer Natural Resources Co. (NYSE:PXD): SunTrust has called Pioneer Natural its new Top Pick, and it thinks that shares have underperformed as a result of concerns regarding its financing needs. The analyst believes that its revolver capacity and net debt to EBITDA through 2014 will continue to be unchanged and views its Midland Basin assets are undervalued. The firm gives the shares a Buy rating and a $6.50 price target.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

PXD

Raptor Pharmaceuticals Corp. (NASDAQ:RPTP): Oppenheimer thinks that the April 30 PDUFA date for Raptor’s Procysbi treatment for Nephropathic Cystinosis will provide a catalyst for the stock. The firm views this disclosure of pricing for the drug within one to two months after the PDUFA date as likely to also provide a catalyst for the stock, and it reiterates its $11 price target and Outperform rating on the shares.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

RPTP

Don’t Miss: What Happens in an Internet Minute?

More from The Cheat Sheet